Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Nortran Pharmaceutical -NRT.V -- Ignore unavailable to you. Want to Upgrade?

To: Rick McDougall who wrote (333)	3/31/1998 9:54:00 PM
From: Paul S.	Read Replies (1) \| Respond to of 1185

I think that the VSE was putting pressure on NRT to produce a NR. I believe that this NR is a (sacrificial lamb) so to speak, obviously something huge is going on. I have to believe that NRT would not want to put out such a weak release when they could hold off until they have the BIG announcement. Unfortunately negotiations are just that but the way this stock is trading they have to be very close. As for Forbes, I do not believe that they have any clinical trials underway. So in my opinion , if NRT signs a deal of the same value as FMI, I would have to say that NRT would well outperform the gains that FMI has recently enjoyed. All I can say is, hold on to your hats.